Elucidating the mechanisms underlying the formation of pathological diversity is expected to contribute greatly to the elucidation of the pathophysiology of not only LRRK2-associated PD but also other neurodegenerative diseases. This evidence concerns the gene LRRK2 and Parkinson disease.